Top

Published in:

01-08-2020 | Guillain-Barré Syndrome | Case Report

Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2

Authors: Paolo Manganotti, Valentina Pesavento, Alex Buoite Stella, Lucia Bonzi, Elena Campagnolo, Giulia Bellavita, Bruno Fabris, Roberto Luzzati

Published in: Journal of NeuroVirology | Issue 4/2020

Abstract

This case report describes the clinical characteristics of a 50-year-old woman that developed SARS-CoV-2 pneumonia and was admitted at the COVID-19 dedicated unit where she developed neurological symptoms 10 days after admission. After neurological examination, including a panel of blood cerebrospinal fluid biomarkers, a diagnosis of Miller Fisher syndrome (MFS) was hypothesized and intravenous immunoglobulin therapy (IVIG) was initiated. Fourteen days after the start of IVIG treatment, the patient has been discharged at home with the resolution of respiratory symptoms and only minor hyporeflexia at the lower limbs, without any side effect.

Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 11:995–998. https://doi.org/10.1021/acschemneuro.0c00122CrossRefPubMedPubMedCentral

Polo A, Manganotti P, Zanette G, De Grandis D (1992) Polyneuritis cranialis: clinical and electrophysiological findings. J Neurol Neurosurg Psychiatry 55:398–400. https://doi.org/10.1136/jnnp.55.5.398CrossRefPubMedPubMedCentral

Pusch E, Renz H, Skevaki C (2018) Respiratory virus-induced heterologous immunity: part of the problem or part of the solution? Allergo J Int 27:79–96. https://doi.org/10.1007/s40629-018-0056-0CrossRefPubMedPubMedCentral

Sellers SA, Hagan RS, Hayden FG, Fischer WA 2nd (2017) The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection. Influenza Other Respir Viruses 11:372–393. https://doi.org/10.1111/irv.12470CrossRefPubMedPubMedCentral

Wakerley BR, Uncini A, Yuki N (2014) Guillain-Barré and Miller Fisher syndromes--new diagnostic classification. Nat Rev Neurol 10:537–544. https://doi.org/10.1038/nrneurol.2014.138CrossRefPubMed

Wattanasit P, Sathirapanya P (2020) Anti-ganglioside antibody-negative Miller Fisher and AMSAN variant Guillain-Barré overlap syndrome. Case Rep Neurol 12:92–96CrossRef

Zhao H, Shen D, Zhou H, Liu J, Chen S (2020) Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 19:383–384. https://doi.org/10.1016/S1474-4422(20)30109-5CrossRefPubMedPubMedCentral

Title: Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2
Authors: Paolo Manganotti
Valentina Pesavento
Alex Buoite Stella
Lucia Bonzi
Elena Campagnolo
Giulia Bellavita
Bruno Fabris
Roberto Luzzati
Publication date: 01-08-2020
Publisher: Springer International Publishing
Keywords: Guillain-Barré Syndrome
Neurological Tests
SARS-CoV-2
COVID-19
Diplopia
Ophthalmoparesis
Published in: Journal of NeuroVirology / Issue 4/2020
Print ISSN: 1355-0284
Electronic ISSN: 1538-2443
DOI: https://doi.org/10.1007/s13365-020-00858-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2020

A candidate gene study of intermediate histopathological phenotypes in HIV-associated neurocognitive disorders

Determinants of neurological syndromes caused by varicella zoster virus (VZV)

Correction to: A candidate gene study of intermediate histopathological phenotypes in HIV-associated neurocognitive disorders

Coronaviruses and the central nervous system

High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients

West Nile virus neuroinvasive disease associated with rituximab therapy